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ABSTRACT 
Background: The purpose of this study to evaluate and 
compare the magnesium concentration in blood plasma and 
saliva of oral squamous cell carcinoma, potentially malignant 
disorders and health subjects to serve as a positive marker or 
indicator in the process of carcinogenesis.
Materials and methods: The study consisted of 30 cases each 
of oral squamous cell carcinoma, potentially malignant disorders 
and healthy subjects of age and sex matched. The estimation 
of magnesium in blood plasma and saliva was carried out by 
colorimeter by using titan yellow method.
Results: There was significantly low concentration of 
magnesium in blood plasma of oral squamous cell carcinoma 
was noted as compared to potentially malignant disorders 
(p = 0.000) and healthy subjects (p = 0.000). However, there was 
no significant difference in magnesium concentration between 
potentially malignant disorders and healthy subjects.
Conclusion: The magnesium concentration was low in both 
blood plasma and saliva of oral squamous cell carcinoma 
as compared to potentially malignant disorders and healthy 
subjects. Thus the magnesium concentration in blood plasma 
and saliva could be considered as tumor marker, playing an 
important role in carcinogenesis. Future studies should be 
carried out for further clarification. 
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INTRODUCTION
Magnesium (Mg) is one of the most abundant cations present 
in living cells. It is an essential mineral that is needed for 
a broad variety of physiological functions. Magnesium 
is considered the physiological calcium antagonist. At a 
cellular level, it may act as an important regulator of cell 
10.5005/jp-journals-10026-1103
functions. Its serum concentration is remarkably constant 
in healthy subjects. The normal Mg serum concentrations 
are protective against various diseases.1 Imbalances in 
magnesium metabolism are common and are associated with 
different pathological conditions.2
Magnesium exerts a large variety of biological functions, 
ranging from structural roles by complexing negatively 
charged groups such as phosphates in nucleic acids, a control 
role in enzyme activation or inhibition, and regulatory role 
by modulating cell proliferation, cell cycle progression and 
differentiation.3
Over 300 enzymes that influence the metabolism of 
carbohydrate, amino acids, nucleic acids and protein, and 
ion transport, require Mg.4,5 It has been proposed that Mg is 
central in the cell cycle, and that its deficiency is an important 
conditioner in precancerous cell transformation.6-8 Optimal 
Mg intake is thought to be prophylactic against initiation of 
some neoplasms.9 
Relationships between magnesium and cancer are 
complex: both Mg load and Mg deficit may produce either 
carcinogenic or anticarcinogenic effects. Carcinogenesis 
modifies the Mg status inducing Mg distribution disturbances 
which may frequently associate a tumor Mg load with Mg 
depletion in non-neoplastic tissues.10-12 Thus, we aim at 
colorimetric estimation of magnesium in blood and saliva 
in oral squamous cell carcinoma and potentially malignant 
disorders so as to serve as a positive marker or indicator in 
the process of carcinogenesis. Also an attempt is made for 
showing how these data can bring about new promising 
developments in cancer research as well as in anticancer 
treatment.
MATERIALS AND METHODS
The present study was carried out after getting the approval 
of the institutional ethical committee. This study consists 
of 30 patients each of oral squamous cell carcinoma and 
potentially malignant disorders. Thirty healthy subjects 
(HS) were matched according to age, sex and ethnicity were 
included in the study. A detailed case history was recorded 
on a case history proforma with special reference to habits 
of betel chewing, smoking and alcohol consumption. 
An informed consent of each patient was obtained after 
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explaining the intended procedure. The HS, comprised 
of healthy individuals with age and sex matched and free 
from any systemic illness or oral habits. Whole blood and 
unstimulated saliva was collected under all aseptic condition. 
Centrifugation of blood was done for plasma collection.
Magnesium Estimation was done with the 
Titan Yellow Method
Principle
A trichloroacetic acid filtrate of serum and saliva is treated 
with the dye titan yellow in alkaline solution. The red lake that 
forms is a dye, adsorbed on the surface of colloidal particles 
of magnesium hydroxide, which are kept ‘in solution with the 
aid of polyvinyl alcohol. This last reagent also increases the 
sensitivity of the method by a factor of approximately 2.13
Procedure
In this study, reagents used were trichloroacetic acid, 
5.0 g/100 ml, sodium hydroxide, 5.0 mol/I, polyvinyl 
alcohol, 0.1 g/100 ml, titan yellow (stock solution), titan 
yellow (working solution) and stock standard, 20 mmol 
Mg~+2/1 and following steps were followed:  
1. Place 1 ml of the unknown blood plasma and saliva 
sample into a 15 × 150 mm test tube and blow in 5 ml 
of trichloroacetic acid, (5 g/l00 ml). Some prefer to use 
trichloroacetic acid, 7.5 g/100 ml.
2. Mix tubes gently but thoroughly, let stand for 5 min, and 
centrifuge for 5 min at 2000 rpm.
3. Transfer 3 ml of the clear supernatant to a Coleman or 
other suitable cuvet.
4. Prepare a standard set by pipetting 0.5 ml of each 
magnesium working standard into a separate cuvet, 
followed by 2.5 ml of trichloroacetic acid (5 g/l00 ml). 
Prepare a reagent blank by substituting distilled water 
for the magnesium standard.
5. Add to all cuvets 2 ml of titan yellow working solution 
and 1 ml of 5.0 molar NaOH. Mix tubes thoroughly and 
read after 5 minutes, but not later than 30 minutes at a 
wavelength of 540 nm with the reagent blank set to 100 
percent T or zero absorbance.13
The instrument used for the measuring of the wavelength 
was digital photo calorimeter (Model no. 312, Electronic 
instrumentation, Bhopal, Madhya Pradesh).
CALCULATION
Construct a standard curve or employ the following formula:
Au
As × Cs = mmol Mg21/2 + /1
Where A = absorbance readings
Cs = concentration of magnesium standard most nearly 
corresponding to the value of the unknown.
The normal concentration range of magnesium in blood 
plasma and saliva using the Titan yellow method is from 
1.4 to 2.3 mmol Mg/1. But for saliva, the concentration is 
more toward the lower limit of the normal range and that 
for blood plasma; it’s more toward the higher side of the 
normal range.13
STATISTICAL ANALYSIS
Statistical analysis was carried out by using SPSS software 
version 16. Kruskalvalis test and Mann-Whitney test was 
done.
RESULTS
OSCC: A total of 30 of OSCC patients comprising of 
21 males (70%) and 09 female (30%) with an age range 
of 40 to 60 years. Out of 30 patients of OSCC, 15 were 
well-differentiated squamous cell carcinoma, 09 were 
moderately differentiated squamous cell carcinoma and 
06 were poorly differentiated squamous cell carcinoma. 
When gender-wise data for occurrence of OSCC was 
analyzed, strikingly these lesions were found to be more 
prevalent in males as compared to females. 
PMD: A total of 30 of PMD patients comprising of 
18 males (60%) and 12 female (40%) with an age range 
of 40 to 60 years. Out of 30 patients, 21 were diagnosed 
as leukoplakia and 09 were diagnosed as erythroplakia. 
Details of histopathological diagnosis are summarized in 








Leukoplakia 09 06 06
Erythroplakia 00 06 03
Table 2: Details of magnesium ion concentration in OSCC, PMD and healthy subjects in blood plasma
Groups N Mean Std. 
deviation
Std. error 95% confidence interval for 
mean
Minimum Maximum
Lower bound Upper bound
1 30 1.9970 0.23796 0.07525 1.8268 2.1672 1.61 2.30
2 30 1.9620 0.26786 0.08471 1.7704 2.1536 1.61 2.30
3 30 0.9210 0.40465 0.12796 0.6315 1.2105 0.38 1.68
Group 1: Healthy subjects; Group 2: PMD; Group 3: OSCC
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Table 1. When gender-wise data for occurrence of PMD 
was analyzed, strikingly these lesions were found to be more 
prevalent in males as compared to females.
HS: The HS consists of apparently healthy individuals 
within age groups of 40 to 60 years. Healthy subjects had 
15 males (50%) and 15 females (50%). None of them had 
acute oral infection or had received any medication. 
Normal magnesium level in blood plasma by calorimetry 
Titan yellow method: –1.4 to 2.3 mmol Mg21/2 + /1. It was 
found significantly low in oral squamous cell carcinoma 
patients but was within normal limits in potentially 
malignant disorders and healthy subjects (Table 2).
Normal magnesium level in Saliva by calorimeter Titan 
yellow method: –1.4 to 2.3 mmol Mg21/2 + /1. It was found 
significantly low in oral squamous cell carcinoma patients 
but was within normal limits in potentially malignant 
disorders and healthy subjects (Table 3).
DISCUSSION
In this study, there was a significant decrease in concentration 
of magnesium noted in blood plasma and saliva in oral 
squamous cell carcinoma than in potentially malignant 
disorder and normal patients, i.e. below 1.4 mmol Mg/l 
carried out by colorimetric Titan yellow method. Studies 
in animal models have found that Mg deficiency has 
caused lymphopoietic neoplasms, osteomyelosclerosis 
and subperiosteal desmoids tumors and intestinal tumor-
like overgrowth in young rats.14-19 Shpitzer T et al studied 
salivary concentrations of Mg was higher in oral cancer by 
28% (p = 0.12), which is not in accordance to this present 
study. This might be due to local therapeutic agents which 
can be easily applied to the oral mucosa, altering its ‘bathing 
medium’-the saliva.20
This is the only study present in the literature carried 
out on human blood plasma and saliva by colorimetric Titan 
yellow method. There are also other studies present in the 
literature which are carried by other methods, however 
comparison cannot be made. Mg has a central regulatory 
role in the cell cycle, that affects transphorylation and 
DNA synthesis, has been proposed as the controller of cell 
growth, rather than Ca.21 This has been related to mitosis 
and division.6-8 It is postulated that Mg controls the timing of 
spindle and chromosome cycles by changes in intracellular 
concentration during the cell cycle, i.e. Mg falls as cells 
enlarge, until it reaches a level that allows for spindle 
formation. Mg influx then causes spindle breakdown and cell 
division. Thus: (1) Mg, not Ca, controls key rate-limiting 
steps in the cell cycle at the onset of DNA synthesis and 
mitosis, a function that may be lost in transformed cells, and 
(2) processes thought to be regulated by Ca/calmodulin are 
Mg-dependent, since low, i.e. Ca levels can be regulators 
only when there is adequate free Mg. The metabolic effects 
of Ca are produced indirectly through its competition with 
Mg for membrane sites.22
Evaluation of the data on the role of Mg in cell 
proliferation indicates absolute requirements in crucial steps 
of cell activation that can trigger normal and neoplastic cell 
division, but the precise phase(s) of cell cycle where Mg 
exerts its regulatory effects is in need of further study. The 
Mg, which is present in a small amount as the free cation, 
or bound to ligands (i.e. the many enzymes it activates), is 
compartmented to a different degree in different types of 
cells; it is not influenced by extracellular Mg concentration.18 
In some cell types rapidly and slowly or nonexchangeable 
compartments are detectable. In gradually Mg depleted 
cells, Mg-dependent metabolic functions are inhibited in 
the following order: glycolysis < RNA and DNA synthesis 
< respiration < protein synthesis protein synthesis appears 
to be the most sensitive function affected.23
Altered membrane phospholipids influence the viscosity 
of membranes, which is decreased both in Mg deficient and 
in cancer cells. Membrane abnormalities of erythrocytes 
of Mg deficient rodents were shown to be responsible for 
their reduced survival time.20 Mg low cell membranes have 
recently been shown to be characterized by increased fluidity 
and permeability.24,25 Changed lipid membrane components 
can reflect changes in lipid metabolism caused by Mg 
deficiency.26 Anghileri et al propose that modifications 
of cell membranes are principal triggering factors in cell 
transformation leading to cancer. Using cells from induced 
cancers, they found that there is much less Mg binding to 
membrane phospholipids of cancer cells, than to normal 
cell membranes. This might be involved in precancerous 
changes; in the preneoplastic phase, binding of Mg to 
Table 3: Details of magnesium ion concentration in OSCC, PMD and healthy subjects in saliva
Groups N Mean Std. 
deviation
Std. error 95% confidence interval 
for mean
Minimum Maximum
Lower bound Upper bound
1 30 1.6850 0.26146 0.08268 1.4980 1.8720 1.32 2.04
2 30 1.5940 0.27814 0.08795 1.3950 1.7930 1.19 2.04
3 30 0.5880 0.32903 0.10405 0.3526 0.8234 0.20 1.23
Group 1: Healthy subjects; Group 2: PMD; Group 3: OSCC
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membranes is decreased at the same time that cytosolic Mg 
increases. There is drastic change in ionic flux from the outer 
and inner cell membranes (higher Ca and Na; lower Mg and 
K levels), both in the impaired membranes of cancer, and 
of Mg deficiency. It has been suggested that Mg deficiency 
may trigger carcinogenesis by altering fidelity of DNA 
replication, and increasing membrane permeability.27-29 
A mechanism proposed is competition of Mg with oncogens 
for DNA binding sites, and its prevention of incorporation 
of incorrect nucleotides during DNA synthesis.
Mg deficiency depresses cell-mediated immunity, impairs 
phagocytic activity as well as lymphocytic function.30 
Mg plays following role in apoptosis –it causes increase in 
DNA fragmentation, cleavage of substrates associated with 
caspase activation and tissue shrinkage.3
Thus, we hypothesize that decrease in Mg content could 
serve as a positive marker or indicator in the process of 
carcinogenesis. This change in values of Mg concentration 
could acts as a screening marker to indicate the progress 
of potential malignant lesions to malignancy. Ease of use 
of saliva as a tool for the use of diagnosis makes this a 
convenient method for mass screening. 
CONCLUSION
Our study finding suggests that Mg deficiency might be 
implicated in aspects of pathogenesis and treatment of 
neoplasms, there are many unknowns. Investigation of these 
questions might lead to means to prevent oral squamous cell 
carcinoma or possibly of immuno-incompetence. Whether 
higher Mg intakes might be protective against oncogens in 
humans as it is in some animal models deserves study.
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